These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 24361342)
1. To the Editor--Propranolol, a β-adrenoreceptor blocker, prevents arrhythmias also by its sodium channel blocking effect. Fabritz L; Franz MR; Carmeliet E; Kirchhof P Heart Rhythm; 2014 Mar; 11(3):e1. PubMed ID: 24361342 [No Abstract] [Full Text] [Related]
2. Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. Schwartz PJ; Crotti L Heart Rhythm; 2014 Mar; 11(3):e1-2. PubMed ID: 24389231 [No Abstract] [Full Text] [Related]
4. Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs. Herrera JA; Ward CS; Pitcher MR; Percy AK; Skinner S; Kaufmann WE; Glaze DG; Wehrens XH; Neul JL Dis Model Mech; 2015 Apr; 8(4):363-71. PubMed ID: 25713300 [TBL] [Abstract][Full Text] [Related]
5. The inherited long QT syndrome: from ion channel to bedside. Vincent GM; Timothy K; Fox J; Zhang L Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of different beta-blockers in the treatment of long QT syndrome. Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637 [TBL] [Abstract][Full Text] [Related]
7. Congenital long QT syndrome with functionally impaired atrioventricular conduction: successful treatment by mexiletine and propranolol. Yao CT; Wang JN; Tsai YC; Lin CS; Wu JM J Formos Med Assoc; 2002 Apr; 101(4):291-3. PubMed ID: 12101867 [TBL] [Abstract][Full Text] [Related]
8. A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers. Toyota N; Miyazaki A; Sakaguchi H; Shimizu W; Ohuchi H Heart Vessels; 2015 Sep; 30(5):687-91. PubMed ID: 25028166 [TBL] [Abstract][Full Text] [Related]
9. Perinatal manifestations of idiopathic long QT syndrome. Mache CJ; Beitzke A; Haidvogl M; Gamillscheg A; Suppan C; Stein JI Pediatr Cardiol; 1996; 17(2):118-21. PubMed ID: 8833499 [TBL] [Abstract][Full Text] [Related]
10. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group. Brooksby P; Robinson PJ; Segal R; Klinger G; Pitt B; Cowley AJ Lancet; 1999 Jul; 354(9176):395-6. PubMed ID: 10437875 [TBL] [Abstract][Full Text] [Related]
11. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Wang DW; Crotti L; Shimizu W; Pedrazzini M; Cantu F; De Filippo P; Kishiki K; Miyazaki A; Ikeda T; Schwartz PJ; George AL Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):370-8. PubMed ID: 19808432 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Dorostkar PC; Eldar M; Belhassen B; Scheinman MM Circulation; 1999 Dec; 100(24):2431-6. PubMed ID: 10595956 [TBL] [Abstract][Full Text] [Related]
14. Role of alpha1-blockade in congenital long QT syndrome: investigation by exercise stress test. Furushima H; Chinushi M; Washizuka T; Aizawa Y Jpn Circ J; 2001 Jul; 65(7):654-8. PubMed ID: 11446501 [TBL] [Abstract][Full Text] [Related]
15. Two Cases of LQT Syndrome with Malignant Syncope after Switch from Propranolol to Bisoprolol. Kesek M; Rydberg A; Jensen SM Pacing Clin Electrophysiol; 2016 Mar; 39(3):305-6. PubMed ID: 26548443 [TBL] [Abstract][Full Text] [Related]
17. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome. Chatrath R; Bell CM; Ackerman MJ Pediatr Cardiol; 2004; 25(5):459-65. PubMed ID: 15534720 [TBL] [Abstract][Full Text] [Related]
18. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3. Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334 [TBL] [Abstract][Full Text] [Related]
19. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. Chockalingam P; Crotti L; Girardengo G; Johnson JN; Harris KM; van der Heijden JF; Hauer RN; Beckmann BM; Spazzolini C; Rordorf R; Rydberg A; Clur SA; Fischer M; van den Heuvel F; Kääb S; Blom NA; Ackerman MJ; Schwartz PJ; Wilde AA J Am Coll Cardiol; 2012 Nov; 60(20):2092-9. PubMed ID: 23083782 [TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3. Bankston JR; Kass RS J Mol Cell Cardiol; 2010 Jan; 48(1):246-53. PubMed ID: 19481549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]